Physician
East End Pediatrics, P.C.
East End Pediatrics, P.C. was paid $6.35M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoEAST END PEDIATRICS, P.C.
EAST HAMPTON, NY 11937
EAST HAMPTON, NY 11937
33aNPI1760407571assigned 07/13/2006
33bProvider typePediatrics Physician
28Total paid$6.35M
24GClaims133,113
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#46 of 1,983
Median peer was paid$17K
This provider vs. median374×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,600 | $822K | |
| 2019 | 22,596 | $870K | |
| 2020 | 20,292 | $783K | |
| 2021 | 19,010 | $1.02M | |
| 2022 | 18,370 | $1.12M | |
| 2023 | 18,107 | $1.02M | |
| 2024incomplete | 12,138 | $713K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 21,976 | 19,844 | $2.14M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 13,073 | 11,716 | $1.60M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.4% | 14,624 | 11,022 | $403K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.0% | 2,802 | 2,796 | $317K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.8% | 2,677 | 2,675 | $303K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 4.3% | 2,149 | 2,106 | $273K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.4% | 4,025 | 3,832 | $213K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 1,955 | 1,939 | $205K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.3% | 1,189 | 1,189 | $149K |
| 99493 | 2.2% | 947 | 944 | $142K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 1.9% | 15,207 | 13,576 | $120K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 1,559 | 1,527 | $78K |
55 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.0% | 1,881 | $64K |
| 99494 | <1% | 716 | $59K | |
| 96127 | <1% | 7,482 | $47K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,891 | $30K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,838 | $28K |
| 92552 | <1% | 781 | $26K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 297 | $22K |
| 99177 | <1% | 850 | $16K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 612 | $14K |
| 87428 | <1% | 209 | $13K | |
| 0072A | <1% | 296 | $12K | |
| 0002A | <1% | 290 | $11K | |
| 0071A | <1% | 262 | $10K | |
| 96160 | <1% | 13,707 | $9K | |
| 0001A | <1% | 247 | $9K | |
| 99051 | <1% | 2,566 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 736 | $4K |
| 0004A | <1% | 97 | $4K | |
| 99173 | <1% | 272 | $4K | |
| 97803 | <1% | 77 | $3K | |
| 83655 | <1% | 93 | $1K | |
| 87081 | <1% | 265 | $1K | |
| 90461 | <1% | 2,211 | $951.85 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 46 | $859.06 |
| 85018 | <1% | 293 | $605.79 | |
| 96161 | <1% | 461 | $603.74 | |
| 90651 | <1% | 70 | $554.78 | |
| 0154A | <1% | 13 | $520.00 | |
| 90686 | <1% | 3,833 | $519.40 | |
| 90697 | <1% | 12 | $498.78 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 29 | $409.75 |
| 90480 | <1% | 12 | $360.00 | |
| 80061 | Lipid panel | <1% | 37 | $336.94 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $305.69 |
| 99050 | <1% | 82 | $301.86 | |
| 90715 | <1% | 71 | $127.37 | |
| 81025 | <1% | 26 | $82.40 | |
| 92558 | <1% | 71 | $69.43 | |
| 90656 | <1% | 323 | $62.08 | |
| 81003 | <1% | 14 | $28.04 | |
| 90680 | <1% | 90 | $17.85 | |
| 36416 | <1% | 292 | $6.32 | |
| 90670 | 0% | 290 | $0.00 | |
| 90671 | 0% | 148 | $0.00 | |
| 91300 | 0% | 104 | $0.00 | |
| 90685 | 0% | 135 | $0.00 | |
| 90633 | 0% | 62 | $0.00 | |
| 99072 | 0% | 17 | $0.00 | |
| 90734 | 0% | 57 | $0.00 | |
| 3008F | 0% | 4,183 | $0.00 | |
| 99000 | 0% | 1,341 | $0.00 | |
| 91307 | 0% | 56 | $0.00 | |
| 90698 | 0% | 40 | $0.00 | |
| 90716 | 0% | 17 | $0.00 | |
| 90619 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHONFELD, GAIL (PRESIDENT)